<?xml version="1.0" encoding="UTF-8"?>
<lom xmlns="http://ltsc.ieee.org/xsd/LOM" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://standards.ieee.org/reading/ieee/downloads/LOM/lomv1.0/xsd/lom.xsd">
<general>
<title>
<string language="el">Designer Xanthone An Inhibitor Scaffold for MDR-Involved Human Glutathione Transferase Isoenzyme A1-1</string>
</title>
<language>eng</language>
<identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/2667</entry>
</identifier>
<subject>
<string language="el">φαρμακευτικό προϊόν</string>
<string language="el">ένζυμο</string>
<string language="el">βιοχημεία</string>
<string language="el">βιοτεχνολογία</string>
</subject>
<description>
<string language="el">Glutathione transferases (GSTs) are cell detoxifiers involved in multiple drug resistance (MDR), hampering the effectiveness of certain anticancer drugs. To our knowledge, this is the first report on well-defined synthetic xanthones as GST inhibitors. Screening 18 xanthones revealed three derivatives bearing a bromomethyl and a methyl group (7) or two bromomethyl groups (8) or an aldehyde group (17), with high inhibition potency (>85%), manifested by low IC50 values (7: 1.59 ± 0.25 μM, 8: 5.30 ± 0.30 μM, and 17: 8.56 ± 0.14 μM) and a competitive modality of inhibition versus CDNB (Ki(7) = 0.76 ± 0.18 and Ki(17) = 1.69 ± 0.08 μM). Of them, derivative 17 readily inhibited hGSTA1-1 in colon cancer cell lysate (IC50 = 10.54 ± 2.41 μM). Furthermore, all three derivatives were cytotoxic to Caco-2 intact cells, with 17 being the least cytotoxic (LC50 = 151.3 ± 16.3 μM). The xanthone scaffold may be regarded as a pharmacophore for hGSTA1-1 and the three derivatives, especially 17, as potent precursors for the synthesis of new inhibitors and conjugate prodrugs for human GSTs.</string>
</description>
<description>
<string language="el">12 pp.</string>
</description>
</general>
<lifecCycle>
<contribute>
<source>LOMv1.0</source>
<value>creator</value>
<entity><![CDATA[BEGIN:VCARD
FN: Zoi, Ourania G.
N: Zoi, Ourania G.
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>publisher</value>
<entity><![CDATA[BEGIN:VCARD
FN: SAGE Journals
N: SAGE Journals
"VERSION:3.0"
END:VCARD]]></entity>
<contribute>
<contribute>
<source>LOMv1.0</source>
<value>Project Final Beneficiary</value>
<entity><![CDATA[BEGIN:VCARD
FN: ΕΛΚΕ Γεωπονικό Πανεπιστήμιο Αθηνών
N: ΕΛΚΕ Γεωπονικό Πανεπιστήμιο Αθηνών
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>Project Executing Organisation</value>
<entity><![CDATA[BEGIN:VCARD
FN: Γεωπονικό Πανεπιστήμιο Αθηνών
N: Γεωπονικό Πανεπιστήμιο Αθηνών
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<date>
<dateStamp>2013-06-07</dateStamp>
</date>
</lifecCycle>
<educational>
<learningResourceType>
<source>Digital Library of the Operational Programme "Education and Lifelong Learning" abstract types</source>
<value>Text</value>
</learningResourceType>
</educational><classification><keyword>
<string language="el">Glutathione transferases</string>
</keyword>
<keyword>
<string language="el">Multiple drug resistance</string>
</keyword>
<keyword>
<string language="el">Cellular detoxification</string>
</keyword>
<keyword>
<string language="el">Xanthones</string>
</keyword>
<keyword>
<string language="el">Inhibitors</string>
</keyword>
<keyword>
<string language="el">Anticancer drugs</string>
</keyword>
<keyword>
<string language="el">GTs</string>
</keyword>
</classification>
<technical>
<location>http://jbx.sagepub.com/content/18/9/1092</location>
</technical>
<technical>
<size>1189823</size>
<format>application/pdf</format>
<location>http://repository.edulll.gr/edulll/bitstream/10795/2667/2/2667_Paper%205.pdf</location>
</technical>
<annotation></annotation><metaMetadata><identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/2667</entry>
</identifier>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>creator</value></role>
<date><dateTime>2016-04-15T07:57:26Z</dateTime></date>
</contribute>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>validator</value></role>
<date><dateTime>2016-04-15T07:57:26Z</dateTime></date>
</contribute>
<metadataSchema>LOMv1.0</metadataSchema>
<language>gre</language>
</metaMetadata>
<rights>
<cost>no</cost>
<copyright>no</copyright>
<description>Copyright EYD-EPEDBM (Operational Programme "Education and Lifelong Learning")</description>
</rights>
</lom>